Nimotuzumab, a humanized monoclonal antibody specific for the EGFR, in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma multiforme: First results in Chinese patients-Reference-Cited by-同舟云学术

Nimotuzumab, a humanized monoclonal antibody specific for the EGFR, in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma multiforme: First results in Chinese patients

Published:2014-01-24 Issue:1 Volume:12 Page:e23-e29
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Wang Yang¹,Pan Li²,Sheng Xiao-fang¹,Chen Shu¹,Dai Jia-zhong¹

Affiliation:

1. Department of Radiation Oncology; Huashan Hospital; Fudan University; Shanghai China

2. Department of Neurosurgery; Huashan Hospital; Fudan University; Shanghai China

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12166/fullpdf

Reference32 articles.

1. Survival analysis of 205 patients with glioblastoma multiforme: clinical characteristics, treatment and prognosis in China;Ma;J Clin Neurosci,2009

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

3. Oncogenic EGFR signaling networks in glioma;Huang;Sci Signal,2009

4. The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data;Chakravarti;Int J Radiat Oncol Biol Phys,2004

5. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo;Ekstrand;Cancer Res,1991

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioblastoma: a comprehensive approach combining bibliometric analysis, Latent Dirichlet Allocation, and HJ-Biplot;Neurosurgical Review;2024-05-10

2. Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings;Brain Sciences;2023-11-17

3. Repurposing drugs in glioblastoma;New Insights Into Glioblastoma;2023

4. Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?;Cancers;2022-11-30

5. Radiotherapy Plus Temozolomide With or Without Nimotuzumab Against the Newly Diagnosed EGFR-Positive Glioblastoma: A Retrospective Cohort Study;The Oncologist;2022-10-01